Candel Therapeutics Inc — Quarterly Cash Flow (NASDAQ:CADL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 106.87 M95.91 M105.97 M93.6 M125.19 M Total liabilities 40.54 M21.23 M15.76 M13.47 M73.27 M Total equity 66.33 M74.67 M90.21 M80.12 M51.92 M Total liabilities & shareholders' equities 106.87 M95.91 M105.97 M93.6 M125.19 M Total debt 11.63 M10.08 M7.64 M5.2 M47.13 M Net debt -91.03 M-82.09 M-93.04 M-81.77 M-72.6 M

뉴스

Candel reports extended survival data for lung cancer therapy

H.C. Wainwright, 캔델 테라퓨틱스에 ’매수’ 의견 유지

H.C. Wainwright reiterates Candel Therapeutics stock rating at buy

캔델, 전립선암 임상 시험 데이터 구두 발표 예정

Candel announces oral presentation on prostate cancer trial data

폴 매닝, 캔델 테라퓨틱스(CADL) 주식 3백만 달러 상당 매입

캔델 테라퓨틱스, 1억 달러 규모 공모에 주가 하락

Candel Therapeutics stock falls on $100 million offering pricing

Why Is Candel Therapeutics Stock Falling Friday? - Candel Therapeutics (NASDAQ:CADL)

New Strong Sell Stocks for January 20th

Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday - Candel Therapeutics (NASDAQ:CADL), Centene (NYSE:CNC)

캔델 테라퓨틱스 목표 주가, Freedom Capital, 14달러로 상향